Abstract
Human epidermal growth factor (hEGF) can stimulate the division of various cell types and has potential clinical applications. However, the high expression of active hEGF in Escherichia coli has not been successful, as the protein contains three intra-molecular disulfide bonds that are difficult to form correctly in the bacterial intracellular environment. To solve this problem, we fused the hEGF gene with a small ubiquitin-related modifier gene (SUMO) by synthesizing an artificial SUMO-hEGF fusion gene that was highly expressed in Origami (DE3) strain. The optimal expression level of the soluble fusion protein, SUMO-hEGF, was up to 38.9% of the total cellular protein. The fusion protein was purified by Ni-NTA affinity chromatography and cleaved by a SUMO-specific protease to obtain the native hEGF, which was further purified by Ni-NTA affinity chromatography. The result of the reverse-phase HPLC showed that the purity of the recombinant cleaved hEGF was greater than 98%. The primary structure of the purified hEGF was confirmed by N-terminal amino acid sequencing and MALDI-TOF mass spectroscopy analysis. Using the method of methylthiazoletetrazolium, the mitogenic activity on Balb/c 3T3 cells of the purified hEGF was comparable to that of commercial hEGF.
Keywords: Human epidermal growth factor, SUMO fusion, protein expression, Escherichia coli
Protein & Peptide Letters
Title: High-Level Expression and Purification of Human Epidermal Growth Factor with SUMO Fusion in Escherichia coli
Volume: 13 Issue: 8
Author(s): Zhijian Su, Yadong Huang, Quannan Zhou, Zhiling Wu, Xiaoping Wu, Qing Zheng, Changcai Ding and Xiaokun Li
Affiliation:
Keywords: Human epidermal growth factor, SUMO fusion, protein expression, Escherichia coli
Abstract: Human epidermal growth factor (hEGF) can stimulate the division of various cell types and has potential clinical applications. However, the high expression of active hEGF in Escherichia coli has not been successful, as the protein contains three intra-molecular disulfide bonds that are difficult to form correctly in the bacterial intracellular environment. To solve this problem, we fused the hEGF gene with a small ubiquitin-related modifier gene (SUMO) by synthesizing an artificial SUMO-hEGF fusion gene that was highly expressed in Origami (DE3) strain. The optimal expression level of the soluble fusion protein, SUMO-hEGF, was up to 38.9% of the total cellular protein. The fusion protein was purified by Ni-NTA affinity chromatography and cleaved by a SUMO-specific protease to obtain the native hEGF, which was further purified by Ni-NTA affinity chromatography. The result of the reverse-phase HPLC showed that the purity of the recombinant cleaved hEGF was greater than 98%. The primary structure of the purified hEGF was confirmed by N-terminal amino acid sequencing and MALDI-TOF mass spectroscopy analysis. Using the method of methylthiazoletetrazolium, the mitogenic activity on Balb/c 3T3 cells of the purified hEGF was comparable to that of commercial hEGF.
Export Options
About this article
Cite this article as:
Su Zhijian, Huang Yadong, Zhou Quannan, Wu Zhiling, Wu Xiaoping, Zheng Qing, Ding Changcai and Li Xiaokun, High-Level Expression and Purification of Human Epidermal Growth Factor with SUMO Fusion in Escherichia coli, Protein & Peptide Letters 2006; 13 (8) . https://dx.doi.org/10.2174/092986606777841280
DOI https://dx.doi.org/10.2174/092986606777841280 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antibacterial and Antiviral Agents: Computational Insight
Current Topics in Medicinal Chemistry SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies
Current Medicinal Chemistry To Study the Spread Curve of Corona Virus in India
Coronaviruses Proteomic Study of Micro-Algae: Sample Preparation for Two-Dimensional Gel Electrophoresis and De Novo Peptide Sequencing Using MALDI-TOF MS
Current Proteomics Rapid Response Research - SARS Coronavirus Vaccines and Application of Processes to Other Emerging Infectious Diseases
Current Immunology Reviews (Discontinued) Nitrogen-Containing Heterocyclic Quinones: A Class of Potential Selective Antitumor Agents
Mini-Reviews in Medicinal Chemistry Anticancer Evaluation and Docking Study of New Bifunctional Phthalazine Derivatives
Current Organic Synthesis Novel Anti-Platelets in Stable Coronary Artery Disease
Current Pharmaceutical Design Design of Inhibitory Peptides of the Interaction between the RBD Domain of the S1 Protein of SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 (ACE2) Receptor
Letters in Drug Design & Discovery Clinical Signs, Prevention and Treatment of Viral Infections in Infants
Infectious Disorders - Drug Targets Future Perspectives in the Pharmacological Treatment of Atrial Fibrillation and Ventricular Arrhythmias in Heart Failure
Current Pharmaceutical Design Imaging Evaluation of Post-Pancreatitis Infection
Infectious Disorders - Drug Targets Naturally Occurring Phenylethanoid Glycosides: Potential Leads for New Therapeutics
Current Medicinal Chemistry Anti-obesity Agents: A Focused Review on the Structural Classification of Therapeutic Entities
Current Topics in Medicinal Chemistry Potential of Selected Indian Herbs for COVID-19
Current Traditional Medicine Recent Advances in PI3 Kinase Inhibitors: Anticancer Activities and Structure-Activity Relationships
Mini-Reviews in Medicinal Chemistry Advances in Research on Pharmacological Activities and Synthesis of Oleanolic Acid Derivatives at C-3 Position
The Natural Products Journal An Insight into Pyrazole-containing Compounds: Synthesis and Pharmacological Activities
Anti-Infective Agents Recent Developments in Oxidative Processes in Steroid Chemistry
Current Organic Chemistry Modulation of γ<sub>2</sub>-MSH Hepatoprotection by Antisense Peptides and Melanocortin Subtype 3 and 4 Receptor Antagonists
Medicinal Chemistry